No Data
No Data
International Medicine: 2024 Semi-Annual Report Summary
International Medicine: Semi-Annual Report 2024
Xi'an International Medical Investment (000516.SZ) released its performance for the first half of the year, with a net loss of 0.173 billion yuan.
xi'an international medical investment (000516.SZ) released the semi-annual report for 2024, with a revenue of 2.42 billion yuan, a year-on-year comparison...
Xi'an International Medical Investment (000516.SZ) has repurchased 0.4865% of its total shares.
Xi'an International Medical Investment (000516.SZ) announced that as of July 31, 2024, the company has repurchased 10,997,100 shares of company stock through the Shenzhen Stock Exchange trading system in a centralized bidding transaction, accounting for 0.4865% of the company's current total share capital. The highest fill price was 5.618 yuan/share and the lowest fill price was 4.61 yuan/share, with a total fill amount of 57,426,831.72 yuan (excluding transaction fees). The progress of the repurchase program complies with relevant laws and regulations and the established share repurchase program of the company.
Xi'An International Medical Investment: 2024 Interim Performance Forecast
Xi'an International Medical Investment (000516.SZ) has spent 57.43 million yuan to repurchase 10.9971 million shares.
Xi'an international medical investment (000516.SZ) announced that as of June 30, 2024, the company has cumulatively passed the Shenzhen...
No Data